ArticleBrain communications2025
Depicting multiple sclerosis disease course using lesion parenchymal fraction: a quantified expression of the topographical model of multiple sclerosis.
Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The topographical model of multiple sclerosis proposes that functional reserve compensates for multiple sclerosis lesions, and that disability accumulation is the result of an insidious unmasking of deficits referable to lesion burden. To utilize topographical principles to establish an imaging metric-lesion parenchymal fraction (LPF)-defined as lesion volume divided by parenchymal volume in the same regional compartment, and to assess the relationship of LPF with disability. One hundred patients with relapsing-remitting or secondary progressive multiple sclerosis were evaluated; clinical and MRI data were longitudinally acquired from 2011-19. Lesion and parenchymal volumes in brain and cervical cord were processed using icobrain/icospine pathways, parsed into topographical compartments, and regional LPF was computed. Performance of LPF-based linear models was evaluated using Pearson correlation and root mean squared error between measured and estimated disability scores (expanded disability status score). To establish relative contributions of LPF in cervical, infratentorial and cerebral compartments, a density plot of weight distributions was generated. Individual disability scores and compartment-weighted LPF trajectories were rendered using matplotlib in Python. MRI and clinical data from 78 patients were sufficient for modelling: 39 remaining relapsing-remitting and 39 progressing to secondary progressive multiple sclerosis. The LPF model had the best performance in decoding the disability score using root mean squared error (1.638) and ranked second in Pearson correlation (0.275). Setting the mean coefficient of cerebral LPF to 1, the cervical compartment had the largest coefficient (3.8), followed by infratentorial (2.5). Compartment-weighted cumulative LPF values depict multiple sclerosis disease trajectory longitudinally on a per-patient basis. This visualization is shown for patients who transitioned from relapsing-remitting to secondary progressive phenotypes; non-progressing patients; and outliers where the LPF model does not approximate the disability score trajectory. We developed and evaluated LPF as an MRI-quantified expression of the topographical model of multiple sclerosis, a first effort to operationalize this model to depict individual disease course. That LPF from spinal cord and infratentorial compartments conferred respectively 3.8 and 2.5 more impact on the expanded disability status score than the cerebral hemispheres emphasizes the importance of lesion topography. Implications of outliers are instructive regarding current model limitations; refinement using additional clinical and imaging metrics could allow application to individual patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.